CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-04 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −7,800 | $74.33 | $580K | 736,019 |
| 2025-09-04 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,300 | $75.22 | $173K | 733,719 |
| 2025-09-04 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 136,569 |
| 2025-09-03 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-09-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,500 | $74.22 | $705K | 744,219 |
| 2025-09-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,500 | $74.63 | $784K | 733,719 |
| 2025-09-03 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 156,569 |
| 2025-09-02 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-09-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −300 | $72.49 | $22K | 753,419 |
| 2025-09-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −16,288 | $73.70 | $1.2M | 737,131 |
| 2025-09-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −3,412 | $74.15 | $253K | 733,719 |
| 2025-09-02 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 176,569 |
| 2025-09-02 | Connaughton Bernadette Director | Sale 10b5-1 | −100 | $71.71 | $7K | 50,852 |
| 2025-09-02 | Connaughton Bernadette Director | Sale 10b5-1 | −2,977 | $73.62 | $219K | 47,875 |
| 2025-09-02 | Connaughton Bernadette Director | Sale 10b5-1 | −923 | $74.11 | $68K | 46,952 |
| 2025-08-13 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-08-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −14,948 | $64.15 | $959K | 738,771 |
| 2025-08-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −5,052 | $64.83 | $328K | 733,719 |
| 2025-08-13 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 196,569 |
| 2025-08-12 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
Page 16 of 26 · 513 trades